Live intraday price
Compare with our price levels
Close 2026-09-30: $681.47 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)
Close to the first target · 5 whales recently bought
🎯 Trade plan by price level
Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks
Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated
Risk : reward 1 : 4.4Moves ~$15.35 a day
⚖️ Positives and risks
- ●เซียนซื้อใหม่/ซื้อเพิ่มไตรมาสล่าสุด 5 ราย
- ●แนวโน้มระยะยาวเป็นขาขึ้น (เหนือ MA200 และ MA200 ชี้ขึ้น)
- ●แข็งแกร่งกว่าตลาด (S&P 500) +20% ใน 6 เดือน
- ●นักวิเคราะห์ส่วนใหญ่แนะนำ Buy
- ●เซียนขายออก/ลดสัดส่วน 3 ราย: Bridgewater (ลด), Mario Gabelli (ลด), Nick Train (ลด)
- ●RSI 74 ซื้อมากเกินไป (Overbought) เสี่ยงย่อตัว
- ●ราคาเกินเป้าหมายนักวิเคราะห์เฉลี่ย 653.11 แล้ว (-4%)
🕯️ Price chart
Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold
🐋 Whales holding this stock
From each whale's latest quarterly filing
👔 Insider buying & selling
Latest trades from SEC Form 4 filings
Pettiti Gianluca · COO
2026-08-31 · 3,733 shares @ $614.38 · pre-planned sale (10b5-1)
Pettiti Gianluca · COO
2026-08-31 · 400 shares @ $614.38 · pre-planned sale (10b5-1)
CASPER MARC N · CEO · Chair · Director
2026-08-24 · 101 shares @ $625.41 · pre-planned sale (10b5-1)
CASPER MARC N · CEO · Chair · Director
2026-08-24 · 79 shares @ $628.01 · pre-planned sale (10b5-1)
CASPER MARC N · CEO · Chair · Director
2026-08-24 · 62 shares @ $628.74 · pre-planned sale (10b5-1)
CASPER MARC N · CEO · Chair · Director
2026-08-24 · 33 shares @ $626.59 · pre-planned sale (10b5-1)
CASPER MARC N · CEO · Chair · Director
2026-08-21 · 3,014 shares @ $626.51 · pre-planned sale (10b5-1)
CASPER MARC N · CEO · Chair · Director
2026-08-21 · 2,727 shares @ $625.46 · pre-planned sale (10b5-1)
CASPER MARC N · CEO · Chair · Director
2026-08-21 · 2,147 shares @ $628.61 · pre-planned sale (10b5-1)
CASPER MARC N · CEO · Chair · Director
2026-08-21 · 1,791 shares @ $627.39 · pre-planned sale (10b5-1)
CASPER MARC N · CEO · Chair · Director
2026-08-21 · 321 shares @ $629.10 · pre-planned sale (10b5-1)
CASPER MARC N · CEO · Chair · Director
2026-08-20 · 2,601 shares @ $628.82 · pre-planned sale (10b5-1)
CASPER MARC N · CEO · Chair · Director
2026-08-20 · 1,430 shares @ $632.01 · pre-planned sale (10b5-1)
CASPER MARC N · CEO · Chair · Director
2026-08-20 · 1,314 shares @ $627.66 · pre-planned sale (10b5-1)
CASPER MARC N · CEO · Chair · Director
2026-08-20 · 1,250 shares @ $629.85 · pre-planned sale (10b5-1)
💬 User reviews
Rate and review this stock (sign-in required) — reviews don't affect the system's scores
Loading…
Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person
📰 Latest news
Thermo Fisher Scientific (TMO) Stock Seems Reasonable Following Its 47% Run
Simply Wall St. · 2026-09-29
Thermo Fisher (TMO) Is Turning Innovation Into Recurring Revenue. Can Margins Follow?
Insider Monkey · 2026-09-29
Will Thermo Fisher’s New cGMP CHO-K1 Panel and MRD Moves Change Thermo Fisher Scientific's (TMO) Narrative
Simply Wall St. · 2026-09-29
Gilead vs. Thermo Fisher: Which Life Sciences Stock has the Stronger Growth Outlook?
Insider Monkey · 2026-09-28
Biodesix Expands MRD Testing With Tumor-Informed and Tumor-Naive Tests
Zacks · 2026-09-28
🤖 The paper-trading bot has traded this stock
🔬 Deep dive
For those who want the detailed numbers